US Stocks
Epizyme Inc
Epizyme Inc

Epizyme Inc (EPZM)


  • $







Key Stats

Today Low/High$1.92 / $2.06
52 Week Low/High$2.04 / $12.37
Market Cap$218.18M

Company Details

Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer and other serious diseases through novel epigenetic medicines. In addition to an active research and discovery pipeline, Epizyme has one U.S. FDA approved product, TAZVERIK® (tazemetostat), for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma (ES) who are not eligible for complete resection; adult patients with relapsed or refractory follicular lymphoma (FL) whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least two prior systemic therapies; and adult patients with relapsed or refractory follicular lymphoma who have no satisfactory alternative treatment options. These indications are approved under accelerated approval based on overall response rate and duration of response. Continued approval for these indications may be contingent upon verification and description of clinical benefit in confirmatory trials. The Company is also exploring the treatment potential of tazemetostat in investigational clinical trials in other solid tumors and hematological malignancies, as a monotherapy and combination therapy in both relapsed and front-line disease settings. By focusing on the genetic drivers of disease, Epizyme seeks to match medicines with the patients who need them..
OrganisationEpizyme Inc
HeadquatersCambridge, Massachusetts, US
IndustryHealth Technology
CEORobert Bazemore

Discover more

Frequently Asked Questions

What is Epizyme Inc (EPZM) share price today?

Can Indians buy Epizyme Inc (EPZM) shares?

How can I buy Epizyme Inc (EPZM) shares from India?

Can Fractional shares of Epizyme Inc (EPZM) be purchased?

What are the documents required to start investing in Epizyme Inc (EPZM) stocks?